Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Carlyle raises $20bn for AlpInvest as secondaries market surges
Carlyle raises $20bn for AlpInvest as secondaries market surges Carlyle Group has raised $20bn for its AlpInvest secondaries platform, positioning the unit as the firm’s fastest-growing business line and a key driver of earnings growth, according to the Financial...
Goldman Sachs launches $25bn push to ease private equity liquidity crunch
Goldman Sachs launches $25bn push to ease private equity liquidity crunch Goldman Sachs is raising $25bn across two new funds aimed at easing liquidity pressures for private equity firms and their portfolio companies, according to a report by Bloomberg. The bank’s...
KKR targets luxury cosmetics supply chain with $528m Samhwa buy
KKR targets luxury cosmetics supply chain with $528m Samhwa buy KKR has completed the acquisition of South Korean cosmetics packaging company Samhwa Co. from TPG in a deal worth $528m (733bn won), Reuters reports. The move adds to KKR’s long history of investments in...